In the short term, people tend to excessively exaggerate the influence of technology, while in the long term, they tend to underestimate it grossly. Although there has been some development, we have not gotten to the point where we&apos;ve entirely changed the way we do trials. &quot;As far as I can tell, the industry is considerably more sophisticated than ever when discussing the advancement of clinical trials today. I believe we must all work together to solve several problems.&quot; - Jacob LaPorte Check out our latest theSpark podcast episode feauting Jacob LaPorte, Co-Founder and VP, Global Head of BIOME - The Digital Innovation Lab by Novartis.

Rethinking the Decentralized Approach to Clinical Trials with Alina Gologan, Associate Clinical Research Manager at Nobel Biocare

This is The Spark, a podcast featuring conversations with life sciences industry leaders who are dedicated to igniting change across the healthcare continuum. Join our host, Derk Arts, and discover what the new frontier of clinical research looks like - and how the industry can lean into change right now. The Spark is brought to you by Castor EDC, a leading provider of decentralized and hybrid clinical trial solutions to democratize research.

Buzzsprout

The Spark

Accelerating trial process with data-driven strategy with Kathleen Wisemandle, Founder and Principal at Aspire to Grow Coaching & Consulting LLC

Leveraging Health Equity Through Effective Digital Health Strategy with Jacob LaPorte, Co-Founder and VP, Global Head of BIOME - The Digital Innovation Lab by Novartis